Hepatitis associated with co-amoxiclav [clavulanate potentiated amoxicillin] therapy
Saudi Medical Journal. 1992; 13 (5): 448-450
Dans Anglais
| IMEMR
| ID: emr-26398
ABSTRACT
A 60-year-old male developed a hepatitis-like syndrome following co-amoxiclav therapy for respiratory infection. Non-specific hepatitis was considered as a diagnosis. A similar attack occurred 2 months later on the third day of co-amoxiclav therapy administered for recurrent respiratory infection. On discontinuation of the treatment, recovery was prompt and complete, with liver enzymes dropping to normal levels. This case illustrates the possibility of a hypersensitivity reaction to co-amoxiclav when the patient was rechallenged. The recent literature documenting hepatic side-effects associated with co-amoxiclav is reviewed
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Acides clavulaniques
/
Hépatite
Type d'étude:
Enquête cas-témoins / Études cas/témoins
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Saudi Med. J.
Année:
1992
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS